Tapewire

Nasdaq · USD

CERS

CERUS CORP

Export transactions ↓
Tapewire entity
5431
SEC CIK
0001020214
Parsed reports
373

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 2026015
Apr 202600
May 202602
Jun 202605
Jul 202601
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2024 Filed Mar 15, 2024 01:30 UTC
Greenman William MarinerDirector · President and CEO
Exercise / conversionCommon Stock 64,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-004848 · doc4.xml · nonDerivative · entry 1

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,307,207

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2024 Filed Mar 15, 2024 01:22 UTC
CORASH LAURENCE MChief Scientific Officer
Exercise / conversionRestricted Stock Unit · Derivative 16,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-004847 · doc4.xml · derivative · entry 4

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F6 · price: Not applicable.

F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2024 Filed Mar 15, 2024 01:22 UTC
CORASH LAURENCE MChief Scientific Officer
Exercise / conversionCommon Stock 16,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-004847 · doc4.xml · nonDerivative · entry 1

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,368,167

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2024 Filed Mar 15, 2024 01:15 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 16,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-004846 · doc4.xml · derivative · entry 4

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F6 · price: Not applicable.

F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2024 Filed Mar 15, 2024 01:15 UTC
Benjamin Richard JChief Medical Officer
Exercise / conversionCommon Stock 16,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-004846 · doc4.xml · nonDerivative · entry 1

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 494,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 08, 2024 Filed Mar 12, 2024 22:10 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 29,378 $2.40 $70,457.26
Disclosure

SEC source: 0001209191-24-004790 · doc4.xml · nonDerivative · entry 1

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 478,061

F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.46 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 23:23 UTC
Moore CarolSVP Reg. & Quality
GrantRestricted Stock Unit 75,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004447 · doc4.xml · nonDerivative · entry 1

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 499,576

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Includes 2,338 and 6,323 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/23 and 02/29/24, respectively.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 23:22 UTC
Jensen ChrystalChief Legal Officer
GrantRestricted Stock Unit 160,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004445 · doc4.xml · nonDerivative · entry 1

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 509,530

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 23:20 UTC
Jayaraman Vivek KChief Operating Officer
GrantRestricted Stock Unit 240,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004444 · doc4.xml · nonDerivative · entry 1

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 906,694

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Includes 2,007 and 6,617 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/23 and 02/29/24, respectively.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 23:18 UTC
Greenman William MarinerDirector · President and CEO
GrantRestricted Stock Unit 575,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004443 · doc4.xml · nonDerivative · entry 1

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,242,541

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Includes 2,578 and 6,617 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/23 and 02/29/24, respectively.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 23:17 UTC
Green Kevin DennisChief Financial Officer
GrantRestricted Stock Unit 200,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004442 · doc4.xml · nonDerivative · entry 1

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 639,639

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Includes 3,676 shares purchased under Issuer's Employee Stock Purchase Plan on 02/29/24, respectively.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 23:16 UTC
CORASH LAURENCE MChief Scientific Officer
GrantRestricted Stock Unit 90,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004441 · doc4.xml · nonDerivative · entry 1

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,351,501

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 23:14 UTC
Benjamin Richard JChief Medical Officer
GrantRestricted Stock Unit 160,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-004440 · doc4.xml · nonDerivative · entry 1

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 507,439

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
December 13, 2023 Filed Dec 13, 2023 22:55 UTC PurchaseCommon Stock 10,000 $1.62 $16,200.00
Disclosure

SEC source: 0001209191-23-058544 · doc4.xml · nonDerivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,133

Read SEC document
August 22, 2023 Filed Aug 23, 2023 22:11 UTC
Lucena AnnDirector
PurchaseCommon Stock 7,500 $1.69 $12,637.50
Disclosure

SEC source: 0001209191-23-047111 · doc4.xml · nonDerivative · entry 1

Lucena Ann · CIK 0001876751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,284

Read SEC document
August 21, 2023 Filed Aug 23, 2023 22:08 UTC PurchaseCommon Stock 10,000 $1.72 $17,151.00
Disclosure

SEC source: 0001209191-23-047110 · doc4.xml · nonDerivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,133

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:17 UTC
Witney FrankDirector
GrantCommon Stock 40,000 $5.00 $200,000.00
Disclosure

SEC source: 0001209191-23-035806 · doc4.xml · nonDerivative · entry 1

Witney Frank · CIK 0001455312 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,059

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:16 UTC GrantCommon Stock 40,000 $5.00 $200,000.00
Disclosure

SEC source: 0001209191-23-035796 · doc4.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,545

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

F2 · balance_after: Since the date of the reporting person's last ownership report, the number of shares beneficially owned by the reporting person has been reduced by 54,263 shares pursuant to the terms of a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:13 UTC
SCHULZE GAILDirector
GrantCommon Stock 40,000 $5.00 $200,000.00
Disclosure

SEC source: 0001209191-23-035770 · doc4.xml · nonDerivative · entry 1

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,420

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:11 UTC GrantCommon Stock 40,000 $5.00 $200,000.00
Disclosure

SEC source: 0001209191-23-035766 · doc4.xml · nonDerivative · entry 1

NACHTSHEIM JAMI K · CIK 0001223017 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,362

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:10 UTC GrantCommon Stock 40,000 $5.00 $200,000.00
Disclosure

SEC source: 0001209191-23-035763 · doc4.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,073

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:08 UTC
Lucena AnnDirector
GrantCommon Stock 40,000 $5.00 $200,000.00
Disclosure

SEC source: 0001209191-23-035757 · doc4.xml · nonDerivative · entry 1

Lucena Ann · CIK 0001876751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,784

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:07 UTC GrantCommon Stock 40,000 $5.00 $200,000.00
Disclosure

SEC source: 0001209191-23-035749 · doc4.xml · nonDerivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,133

F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.

Read SEC document
May 26, 2023 Filed May 30, 2023 19:45 UTC PurchaseCommon Stock 5,000 $1.91 $9,535.00
Disclosure

SEC source: 0001209191-23-032850 · doc4.xml · nonDerivative · entry 1

Swisher Daniel N JR · CIK 0001323113 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,808

F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.905 to $1.910 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth.

Read SEC document
May 24, 2023 Filed May 24, 2023 23:18 UTC
SCHULZE GAILDirector
PurchaseCommon Stock 9,850 $2.03 $19,980.73
Disclosure

SEC source: 0001209191-23-032014 · doc4.xml · nonDerivative · entry 1

SCHULZE GAIL · CIK 0001023259 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,420

F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.025 to $2.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth.

Read SEC document
May 23, 2023 Filed May 23, 2023 21:57 UTC PurchaseCommon Stock 5,000 $2.00 $10,000.00
Disclosure

SEC source: 0001209191-23-031710 · doc4.xml · nonDerivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,133

Read SEC document
March 13, 2023 Filed Mar 15, 2023 00:00 UTC
Moore CarolSVP Reg. & Quality
SaleCommon Stock 3,350 $2.80 $9,380.00
Disclosure

SEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 4

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 415,915

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 00:00 UTC
Moore CarolSVP Reg. & Quality
SaleCommon Stock 9,728 $2.80 $27,238.40
Disclosure

SEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 2

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 407,598

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:56 UTC
Jayaraman Vivek KChief Operating Officer
SaleCommon Stock 8,791 $2.80 $24,614.80
Disclosure

SEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 4

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 658,070

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:56 UTC
Jayaraman Vivek KChief Operating Officer
SaleCommon Stock 16,565 $2.80 $46,382.00
Disclosure

SEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 2

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 641,861

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:50 UTC
Jensen ChrystalChief Legal Officer
SaleCommon Stock 5,758 $2.80 $16,122.40
Disclosure

SEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 4

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,530

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:50 UTC
Jensen ChrystalChief Legal Officer
SaleCommon Stock 9,710 $2.80 $27,188.00
Disclosure

SEC source: 0001209191-23-018684 · doc4.xml · nonDerivative · entry 2

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,621

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:47 UTC
Greenman William MarinerDirector · President and CEO
SaleCommon Stock 22,732 $2.80 $63,649.60
Disclosure

SEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 4

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,658,346

F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:47 UTC
Greenman William MarinerDirector · President and CEO
SaleCommon Stock 37,748 $2.80 $105,694.40
Disclosure

SEC source: 0001209191-23-018683 · doc4.xml · nonDerivative · entry 2

Greenman William Mariner · CIK 0001377258 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,616,411

F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:43 UTC
Green Kevin DennisChief Financial Officer
SaleCommon Stock 7,501 $2.80 $21,002.80
Disclosure

SEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 4

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 435,963

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:43 UTC
Green Kevin DennisChief Financial Officer
SaleCommon Stock 9,662 $2.80 $27,053.60
Disclosure

SEC source: 0001209191-23-018681 · doc4.xml · nonDerivative · entry 2

Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,797

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:38 UTC
CORASH LAURENCE MChief Scientific Officer
SaleCommon Stock 5,745 $2.80 $16,086.00
Disclosure

SEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 4

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,261,501

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:38 UTC
CORASH LAURENCE MChief Scientific Officer
SaleCommon Stock 9,597 $2.80 $26,871.60
Disclosure

SEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 2

CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,250,579

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:34 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 10,000 $2.78 $27,793.00
Disclosure

SEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 5

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,439

F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.895 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:34 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 5,747 $2.80 $16,091.60
Disclosure

SEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 4

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 357,439

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 23:34 UTC
Benjamin Richard JChief Medical Officer
SaleCommon Stock 9,606 $2.80 $26,896.80
Disclosure

SEC source: 0001209191-23-018677 · doc4.xml · nonDerivative · entry 2

Benjamin Richard J · CIK 0001296322 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,519

F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person.

F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Read SEC document
March 12, 2023 Filed Mar 15, 2023 00:00 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionRestricted Stock Unit · Derivative 11,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018688 · doc4.xml · derivative · entry 6

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,666

Underlying: Common Stock · 11,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2023 Filed Mar 15, 2023 00:00 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionRestricted Stock Unit · Derivative 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018688 · doc4.xml · derivative · entry 5

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,460 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

Read SEC document
March 12, 2023 Filed Mar 15, 2023 00:00 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionCommon Stock 11,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 3

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 15, 2023 00:00 UTC
Moore CarolSVP Reg. & Quality
Exercise / conversionCommon Stock 23,460 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018688 · doc4.xml · nonDerivative · entry 1

Moore Carol · CIK 0001574700 · SVP Reg. & Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,326

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:56 UTC
Jayaraman Vivek KChief Operating Officer
Exercise / conversionRestricted Stock Unit · Derivative 25,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018685 · doc4.xml · derivative · entry 6

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:56 UTC
Jayaraman Vivek KChief Operating Officer
Exercise / conversionRestricted Stock Unit · Derivative 44,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018685 · doc4.xml · derivative · entry 5

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 44,200 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:56 UTC
Jayaraman Vivek KChief Operating Officer
Exercise / conversionCommon Stock 25,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 3

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 666,861

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:56 UTC
Jayaraman Vivek KChief Operating Officer
Exercise / conversionCommon Stock 44,200 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018685 · doc4.xml · nonDerivative · entry 1

Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 658,426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

Read SEC document
March 12, 2023 Filed Mar 14, 2023 23:50 UTC
Jensen ChrystalChief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 16,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018684 · doc4.xml · derivative · entry 6

Menard Chrystal · CIK 0001564252 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,666

Underlying: Common Stock · 16,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.

F5 · price: Not applicable.

F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.